IP Library Granted Patent US 9,428,455
Granted Patent B2
US 9,428,455 · App. 14/688,451 · Granted Aug 30, 2016

Process for annealing amorphous atorvastatin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,428,455
App. No.
14/688,451
Granted
Aug 30, 2016
Kind
B2
Abstract

Processes for annealing amorphous atorvastatin is described. Pharmaceutical compositions and formulations containing annealed amorphous atorvastatin are also described.

Claims (10)

1. A process for annealing amorphous atorvastatin admixed with a pharmaceutically acceptable diluent, carrier, or excipient at elevated temperature comprising heating at ambient pressure amorphous atorvastatin in an essentially solvent-free system wherein no additional solvent is added to a temperature of between approximately 50° C. to approximately 140° C.; holding said temperature for approximately 30 minutes to approximately 12 hours; and cooling the resulting annealed amorphous atorvastatin.

2. A process for annealing amorphous atorvastatin at elevated or high pressure comprising treating amorphous atorvastatin in an essentially solvent-free system wherein no additional solvent is added at a pressure of between approximately 0.1 kBar to approximately 250 kBar at a temperature of between ambient temperature to approximately 150° C. for approximately 1 minute to approximately 30 days.

3. The process of claim 2 , wherein said pressure is between approximately 0.5 kBar and approximately 200 kBar.

4. The process of claim 2 , wherein said pressure is between approximately 0.5 kBar and approximately 10 kBar.

5. The process of claim 2 , wherein said temperature is between approximately 25° C. and approximately 80° C.

6. The process of claim 2 , wherein said time is between approximately 30 minutes and approximately 12 hours.

7. The process of claim 2 , wherein said pressure is cycled between about ambient pressure and about 200 kBars two or more times.

8. The process of claim 2 , wherein said amorphous atorvastatin is amorphous atorvastatin calcium.

9. The process of claim 2 , wherein said amorphous atorvastatin is admixed with a pharmaceutically acceptable diluent, carrier, or excipient prior to said treating step.

10. The process of claim 2 , wherein said amorphous atorvastatin is treated with a plasticizer prior to or during the annealing process.

Assignments (2)
CHANGE OF NAME Recorded Oct 31, 2022
From: UPJOHN US 1 LLC
To: VIATRIS SPECIALTY LLC.
Reel/Frame 061808/0420 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2020
From: PFIZER INC.
To: UPJOHN US 1 LLC
Reel/Frame 054293/0154 →